Medtronic's SYMPLICITY HTN-3 Long-Term Data Presented
September 18, 2022—Medtronic announced the presentation of long-term results from the SYMPLICITY HTN-3 clinical trial. In the randomized control
United States Deepakl Bhatt Jeffrey Popma American College Of Cardiology Professor Of Medicine At Harvard Medical School Cardiovascular Research Foundation
Source: evtoday.com